Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
26/08/2025
Lai publishes the results of the second obesity trial of Orforglipron, the drug resulted in a 9.6% weight loss for obese and diabetic patients, and plans to apply for approval of the weight loss drug in 2025.
Latest
1 m ago
Chaojie Group (301005.SZ) releases its first half year performance, with a net profit attributable to the parent company of 21.72 million RMB, an increase of 21.86%.
1 m ago
Tianchen Medical: Net profit in the first half of the year increased by 67.1% year on year, planning to distribute 5 yuan per 10 shares.
2 m ago
Hualian Holdings (000036.SZ) released its performance for the first half of the year, with a net profit attributable to the parent company of 2.0356 million yuan, a year-on-year decrease of 93.84%.
2 m ago
Canadian Geese: Costs have increased due to marketing and store investment, but are expected to decrease as scale expands.
2 m ago
Canadian geese: costs have increased due to marketing and store investments, but are expected to decrease as scale expands.
See all latest